C9orf72 and frontotemporal dementia: There are two mutually non-exclusive mechanisms for C9ORF72 expansion-induced pathogenesis in ALS/FTD, gain of function from the presence of toxic RNA and dipeptide repeats3,4, and loss of function due to reduced C9orf72 protein expression5–7.